-
Aug 04, 2011The safety of Adenovirus type 5 as a vaccine vector is validated at GIBHRecently, a research team led by visiting investigator Dr. Lin Chen from GIBH published its research result Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, Southern China in Vac...
-
Jul 15, 2011GIBH welcomes Mr. Xuerong XingGIBH welcomes Mr. Xuerong Xing, who is a new deputy directorand one of his numerous duties include enabling intellectual pro-perty licensing technology transfer in Asia. -
Jul 15, 2011GIBH welcomes Mr. Xuerong XingGIBH welcomes Mr. Xuerong Xing, who is a new deputy directorand one of his numerous duties include enabling intellectual pro-perty licensing technology transfer in Asia. -
Jul 15, 2011Generation of human induced pluripotent stem cells from urineA research team led by Dr. Miguel Esteban and Dr. Duanqing Pei from GIBH has successfully generated human induced pluripotent stem cells from urine. This work was lately published in the internationally prestigious nephrological journal:...
-
Jul 15, 2011Generation of human induced pluripotent stem cells from urineA research team led by Dr. Miguel Esteban and Dr. Duanqing Pei from GIBH has successfully generated human induced pluripotent stem cells from urine. This work was lately published in the internationally prestigious nephrological journal:...
-
May 26, 2011GIBH Makes Significant Progress in Dioxygen ActivationVery recently, a research group led by Dr. Qiang Zhu at GIBH made significant progress in copper-catalyzed dioxygen activation. The study shows that molecular dioxygen could be activated and incorporated into small molecules, forming for...